Article

ThinkLive Cell and Gene Therapy Summit 2024

Explore highlights from the Inaugural ThinkLive Cell and Gene Therapy Summit, which unfolded on May 14-15, 2024. Over two days, global and emerging company leaders, providers, and experts converged at this virtual summit to delve into the future of healthcare. The event served as a platform where over 30 speakers across 10 sessions explored six key focus areas at the forefront of healthcare innovation.

Summit Insights

Dive into a curated selection of insights crafted to deepen your comprehension of the ever-evolving landscape of innovative therapies. From uncovering the latest trends and strategies fueling commercial success to unraveling the complexities of patient access on a global scale, you will find insights and learnings on the forces driving the field forward. 

thinklive

Takeaways from Cencora’s inaugural Cell and Gene Therapy Summit

Lab tech with DNA

Adapting learnings to advance CGT clinical manufacturing

webinar

Leveraging past learnings for future-focused solutions to clinical manufacturing

CGT

Breaking barriers and moving forward: Reflections on impact and future directions for CGT

A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

A glimpse into the future of CGTs with ARM’s Rita Johnson-Greene
 

Doctor with patient

The power of patient engagement with CGT innovation

The power of patient engagement: A trailblazing journey to elevate access

Protecting your Supply Chain

Tackling the complex nature of the cell and gene therapy supply chain

Navigating the supply chain maze: Overcoming challenges and optimizing logistics for CGTs

Dr Verdun

Navigating the future of CGT: Insights from the FDA

DNA double helix

Unwinding the patient journey: Simplifying experiences and overcoming patient access barriers

Building trust in uncharted territory: Patient considerations for embracing Cell and Gene Therapies

CGT cells

Optimizing channel strategy to overcome CGT-specific barriers

Channel strategy for a rare disease product

Optimizing the channel strategy to expand patient access to cell and gene therapies

Thinking proactively about accessing target markets

Hospital distribution channels

Best practices for building a channel strategy: Lessons learned and forward-thinking initiatives to maximize market reach

Navigating the CGT landscape: Commercial considerations, strategic investments, and effective collaborations
 

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.

Related resources

Webinar

Data Governance & AI in Pharma: Overcoming challenges in DACH region
Learn More

White paper

Capitalizing on biotech collaboration: A CFO’s guide to driving growth
Learn More

Article

The future promise of advanced therapies in ophthalmology
Learn More

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.